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Over the past four decades, growing evidence has indicated that characteristics such as birth 
weight and length of gestation are not only key indicators for infant’s health, but also 
predictors of adult health and disease risk. These findings lend support to the developmental 
origins of health and disease theory. However, evidence remains inconclusive in terms of 
female hormone-related disorders, including endometriosis and perimenopausal disorders. 
Also, little is known about the social patterning of these female health burdens from 
population-based studies. Furthermore, the psychological health of women with 
endometriosis has not been adequately explored in longitudinal studies.  
Based on identified knowledge gaps and taking advantage of Swedish high-quality 
population-based registers, this thesis aims to study how factors operating during early life, 
such as parental and birth characteristics, adult socioeconomic and reproductive factors are 
associated with subsequent risks of endometriosis and perimenopausal disorders. Further, it 
explores whether women with endometriosis have higher risk of psychiatric comorbidity. 
Study I explored the associations of early life social and health characteristics with risk of 
endometriosis in a cohort of the second generation of women from the Uppsala Birth Cohort 
Multigenerational Study. Lower birth weight-for-gestational age, fewer births, and previous 
infertility disorder were found to be associated with an increased risk of endometriosis. 
Nevertheless, the inverse association between low birth weight-for-gestational age and 
endometriosis could not be explained by women’s lower number of live births in adulthood.   
Study II replicated the original findings in Study I in a nationwide population-based cohort of 
females born in Sweden between 1973 and 1987. This study confirmed the inverse 
association between fetal growth rate and risk of endometriosis, and expanded Study I by 
showing associations of maternal smoking during pregnancy and lower maternal education 
with endometriosis risk in early to mid-adulthood. The study also found a part of the 
association between maternal smoking and risk of early-onset of endometriosis was due to 
slow fetal growth.  
Study III focused on the psychological health of women with endometriosis by assessing the 
bi-directional associations of endometriosis with all psychiatric disorders, as well as the role 
of familial confounding, in a nationwide cohort of all women born in Sweden in 1973-1990. 
Statistically significant bi-directional associations were found for endometriosis with many 
different types of psychiatric disorders, including affective psychotic disorders, depressive, 
anxiety and stress-related disorders, eating disorders, alcohol/drug dependence, personality 
disorders, and attention-deficit hyperactivity disorder. These bi-directional associations 
observed at the population level largely remained in comparisons between exposed and 
unexposed sisters, suggesting that shared familial liability may not fully explain these 
associations.  
Study IV investigated the developmental origins of three subtypes of perimenopausal 
disorders using the same cohort as Study I. Positive association between birth weight and a 
clinical diagnosis of menopausal and climacteric states was found. Higher risk of being 
diagnosed with other perimenopausal disorders (e.g., atrophic vaginitis) was observed among 
women born with shorter gestational age. This study also documented that women with 
higher parental and own educational level in adulthood were more likely to be diagnosed with 
perimenopausal disorders. 
Taken together, this thesis supports the developmental origins of two important female 
hormone-related disorders during reproductive age and menopause, namely endometriosis 
and perimenopausal disorders. Our findings highlight the importance of intrauterine 
environment in shaping the developmental adaptations of metabolism and organ function. In 
addition to the developmental origins, these female health burdens were associated with a 
range of socioeconomic and reproductive factors as well as mental health in earlier life. It is 
therefore important to take a life-course perspective for a greater understanding of the 
etiology of hormone-related health outcomes and consider potential targeting of the high-risk 
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Endometriosis is a chronic estrogen-dependent inflammatory condition commonly manifest 
among women of reproductive age.1 It is characterized by the ectopic presence of endometrial 
tissue (e.g., glands and stroma) outside its usual physiological site.2 As signs for the final 
stage of women’s reproductive life, perimenopausal disorders (PDs) are a group of symptoms 
induced by the variations in reproductive hormone levels or gynecological lesions, occurring 
during and after menopause, frequently including a range of vasomotor, psychological, 
somatic and vaginal symptoms.3-6 Both disorders are highly prevalent and associated with a 
range of adverse physiological and psychological consequences, which could directly 
threaten women’s health-related quality of life, and indirectly bring significant burdens to the 
healthcare system and society.7-12 Apart from established genetic susceptibility,6,13 the 
etiology of these disorders (including their potential developmental origins) that could 
provide important clues for reducing these health burdens, remains unclear.  
The developmental origins of health and disease (DOHaD) theory was built upon the well-
known “fetal origins of adult disease” hypothesis, which was proposed by Professor David 
Barker and colleagues to describe the associations between intrauterine environmental 
exposures and risk of chronic diseases in adult life.14,15 In light of the DOHaD theory, recent 
research demonstrates that in addition to genetic impact, human body is in constant 
developmental changes and makes adaptations to many modifiable factors, such as 
intrauterine environment or nutrient supply.14,16 This programming effect may particularly 
apply to hormone-driven disorders, considering the permanent impact from changes in 
prenatal endocrine status and hormonal environment on hormone secretion and tissue-specific 
hormone susceptibility across the life course.17 It is therefore needed to explore the potential 
developmental mechanism of factors operating during perinatal and earlier life in contribution 
to adult hormone-related disorders.  
Despite emerging research interest in the intrauterine programming of endometriosis, to date, 
evidence has been conflicting and inconclusive.18-22 Findings regarding the association 
between in utero exposure to maternal smoking and risk of endometriosis are also 
complex.18,21-24 These discrepancies in the existing literature may result from low statistical 
power and usage of retrospectively self-reported information on perinatal characteristics in 
many of the earlier studies.18,21-24 Additionally, it is worthwhile to explore the socioeconomic 
inequalities in endometriosis in population-based cohorts from a country with egalitarian 
healthcare system.    
Although it has been documented that women with endometriosis suffer from worse mental 
health, such as anxiety and depressive disorders,25,26 the temporal sequence between these 
disorders as well as the mechanism underlying them remain unclear. Moreover, it is still 
unknown whether there is comorbidity between endometriosis and a broader spectrum of 
psychiatric disorders, such as alcohol or drug dependence disorders, personality disorders, 
and attention-deficit/hyperactivity disorder. Thus, research is warranted that attempts to 
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disentangle the bi-directional association between endometriosis and mental disorders across 
the life course.  
With regard to the significant health burden in women’s midlife, previous studies have 
suggested that there might be developmental origins of ovarian aging, given that a positive 
association was found between birth weight and earlier age at menopause.27,28 However, 
whether birth characteristics are associated with the occurrence of clinically diagnosed PDs is 
not clear yet. 
This thesis, therefore, focuses on the developmental origins of important female hormone-
related disorders during the reproductive period and menopause, namely endometriosis and 
PDs, as well as their associations with socioeconomic factors and psychiatric comorbidities 
across the life course. We hope our findings may shed further light on the etiology of these 
important disorders burdening women, as well as help to identify the groups of women who 






2 LITERATURE REVIEW 
2.1 THEORETICAL BACKGROUND 
2.1.1 A life course approach to health 
As defined by Ben-Shlomo and Kuh, the life course approach explores the associations of 
physical or/and social exposures operating during gestation, childhood, adolescence, and 
adult life with subsequent heath and disease risk in later life or across generations.29 It also 
focuses on investigating the underlying interrelationship between biological, behavioral and 
psychosocial pathways that contribute to the life course associations between early life 
exposures and adult health outcomes.30  
Besides focusing on individuals’ life spans, the life course approach additionally puts an 
emphasis on the intergenerational effects.30 A frequently studied topic is the effect of 
maternal health behaviors during pregnancy on health outcomes in offspring. For instance, 
maternal smoking during pregnancy has been linked to both short-term and long-term adverse 
health consequences in offspring, such as lower birth weight,31,32 attention-deficit 
hyperactivity disorder,33,34 cardiovascular disease,35 and respiratory disease.36,37 The 
application of a life course perspective in exploring the intergenerational biological and social 
exposures may help to understand how they contribute to the reproduced ill-health across 
several generations. 
A thorough investigation of the temporal relationship of different biological, psychological, 
and social exposures across the life course is another important aspect in life course 
epidemiology. The association between an early life exposure and adult health outcome could 
be confounded by many factors prior to the examined exposure. Ben-Shlomo and colleagues 
have advocated that such confounding bias can be largely eliminated through family-based 
designs, which could also help infer causality in a life course association.29 Therefore, 
disentangling the role of confounding underlying any observed association is a priority aim of 
this thesis.  
Furthermore, the life course perspective considers the timing of an exposure as a key 
contributing factor to health inequalities. For example, if an exposure can only exert a risk 
effect on subsequent health within a certain time window, then the time window is defined as 
the critical period.29 A classic example is the effect of maternal intrauterine undernutrition on 
offspring’s health. Based on the Dutch Hunger Winter Families study,38 prenatal exposure to 
famine particularly during early gestation was associated with obesity and breast cancer in 
offspring. By contrast, exposure to famine during late gestation was associated with a 
decreased risk of obesity in adulthood.39 Such findings also suggest that the effect of stimuli 
or insults during the critical period of life may have long-term influence on health and may 
not be reversible.  
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With regard to the timing of exposures, the life course approach also highlights the need for 
investigation of the underlying causal pathways. For example, the life course chain of risk 
additive model describes a situation where each exposure could increase disease risk 
independently, meanwhile these exposures are temporally and causally linked with each 
other.29 In light of this, the current thesis also aims to disentangle the direct effect of an 
exposure from its total effect on certain disease risk, as well as explore indirect pathway of 
the respective intermediate exposure, which can further illustrate the disease mechanism.  
Adopting a life course approach is particularly important with respect to women’s health. 
Women’s health can specifically be affected by their reproductive careers or behaviors, such 
as number of pregnancies, age at first and last birth, and health behaviors during pregnancy, 
which can be determined by a hierarchy of socioeconomic, environmental, and cultural 
circumstances. To this end, circumstances around pregnancy and childbirth are important in 
the life course of women as well as for their offspring’s health.  
2.1.2 The developmental origins of health and disease theory 
The developmental origins of health and disease (DOHaD) theory resonates with and is an 
important part of life course epidemiology.40 The DOHaD thoery originates from the “fetal 
origins of adult disease” hypothesis, which was proposed by Professor David Barker and 
colleagues to describe their findings on the associations between birth weight and increased 
risks of certain adult diseases, such as coronary heart disease, type 2 diabetes, stroke and 
hypertension.14,15,41 The hypothesis proposes that a stimulus or insult acting during the critical 
or sensitive period of life could exert a long-term permanent impact on body structure, 
function and metabolism.17 Considering the critical period in utero for most organs’ and 
systems’ programming, the hypothesis has often been referred as the “fetal programming” 
hypothesis.42  
The biological basis behind the hypothesis is related to the developmental plasticity of human 
body. As such, the hypothesis highlights the importance of nutrition during the fetal stage or 
infancy in shaping the developmental adaptations across the life course, which in turn could 
affect adult biological outcomes. According to Barker, plasticity during the in utero period 
allows humans to make short-term adaptations according to their perceived maternal 
nutritional or hormonal signals.14 These adaptations are predictions and preparations for 
future environment.43 For example, if an infant was exposed to undernutrition in utero, he or 
she will likely have a decreased body size and altered metabolism to adapt to the forthcoming 
deprived environment in postnatal life.14 Fetal growth rate is thus generally believed to be an 
indicator for fetal nutrition and environment. 
Barker and colleagues describe the result of fetal growth restriction or low birth weight as an 
undernourished fetus’s “thrifty” way of survival through mechanism of insulin resistance.14 
This developmental process has been named as a “thrifty phenotype”.44 The thrifty phenotype 
will increase infant’s chance of survival in nutritionally constrained prenatal and postnatal 
environments. The mismatch between e.g., placental nutrient supply and fetal nutrient 
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demand will trigger fetal protective mechanism through a series of physiological or genetic 
adaptations.17 Issues will however come up when there is another mismatch between 
intrauterine and postnatal environments, usually deficient intrauterine environment does not 
predict similar milieu postnatally.43 Under such mismatched condition, the thrifty phenotype 
can be a disadvantage for later development and survival, and increases susceptibility to 
several adverse health outcomes, such as metabolic syndrome or heart diseases.44,45 
The fetal origins hypothesis has been later expanded to the DOHaD theory to further illustrate 
the impact of nutritional, hormonal and metabolic environments in utero and continuously 
through early life development on adult health,42,46,47 as well as to identify potential 
modifiable factors across the life course. 
2.1.3 Social determinants of health 
Apart from biological influences, individual’s health is also determined by a range of 
socioeconomic circumstances, such as social support, social network, living and working 
conditions, as well as general socioeconomic and cultural environments.48 All these social 
determinants are embedded in the social context in which individuals live, develop, and age, 
and will shape one’s health directly or indirectly by influencing health-related factors. These 
include lifestyle, health awareness, behaviors, and knowledge, as well as material resources 
or ability to access to healthcare. Individual’s position in the social spectrum will determine 
one’s vulnerability to ill-health through a chain of influences from a hierarchy of 
socioeconomic circumstances. At the population level, social determinants of health will 
become apparent as health inequalities or social gradients in health. 
Concomitantly, a main objective of life course research is to clarify the underlying biological, 
behavioral and socioeconomic processes that contribute to the relationship between certain 
exposure and outcome within one’s lifetime or across generations.49 To this end, this thesis 
also focuses on understanding how socioeconomic circumstances across the life course may 
affect women’s health in adult life, and their indirect influences through interacting with other 
biological or psychological factors. 
2.2 ENDOMETRIOSIS 
Endometriosis is an estrogen-dependent, chronic gynecological disorder commonly found 
among women of reproductive age.1 It is characterized by the abnormal presence of 
endometrial-like tissue (i.e., glands and stroma) from its usual physiological site.2 
Endometriosis is commonly found on the pelvic peritoneum, but could also occur for 
example, in the ovaries, fallopian tubes, intestine, or rectovaginal septum.9 A special case of 
endometriosis is when the detached endometrial tissue moved from the endometrium layer to 
other parts of the uterus, usually to the myometrium layer.50 This condition is also referred to 




There is no general agreement on the prevalence of endometriosis, which varies between 1.3 
and 5% among reproductive-aged women according to population-based studies,8,51-53 while 
it approaches 6-10% in hospital-based studies.1 Potential cause for the variations in reported 
prevalence is that women with pathophysiological signs of endometriosis could experience 
different degrees of symptoms, some may even have no symptom and therefore do not seek 
medical care. It is estimated that around 11% of all women could have undiagnosed 
endometriosis.54 Apart from that, women with endometriosis may experience serious 
diagnostic delay, studies have shown that the lag time between onset of symptoms and a 
definitive diagnosis ranges from 4 to 10 years.55,56 Also, the diagnostic criteria for 
endometriosis vary from time to time and differ between countries. For example, although 
laparoscopy has been referred to as the only reliable diagnostic test to confirm 
endometriosis,57 it is not a requirement for endometriosis diagnosis in every country, take 
Sweden for instance. Nonetheless, study has estimated that around 80% of endometriosis 
cases recorded in the Swedish inpatient register were histologically confirmed.58  
2.2.2 Etiology  
Though the pathologic description of endometriosis was first introduced in 1860,59 the 
etiology of endometriosis is still poorly known. Several theories have been proposed to reveal 
the pathogenesis of endometriosis, the most accepted and convincing one is the retrograde 
menstruation/implantation theory.60,61 According to the theory a prerequisite for the 
development of endometriosis is menstrual reflux, i.e., during menstruation viable 
endometrial fragments are retrograded through the fallopian tubes and implanted in the 
peritoneal cavity.1,62 Apart from that, other sufficient conditions have to be met, which 
involve immune dysfunction, inflammatory response and incapacity of cleaning the implants 
(i.e., lesions).60 
Genetic variant has been shown in recent twin and genome-wide association studies to 
contribute to endometriosis, which may account for 51% of the variance in liability.13,63 Apart 
from genetic origins, the development and establishment of endometriosis also require 
multiple mechanisms operating throughout the life course, including immune system 
dysfunction, molecular alterations, metabolism and hormonal regulations.52,64 Thus, it is 
reasonable to assume that the disorder is a complex outcome of gene-by-environment 
interactions in different life stages, which may start already from prenatal period.  
2.2.3 Developmental origins of endometriosis 
Birth weight and gestational age 
There is no general agreement on the developmental origins of endometriosis. Previous 
evidence regarding the associations of birth characteristics with risk of endometriosis is 
inconsistent and debatable. Some studies have provided evidence of the development origins 
of endometriosis. In a case-control study by Vannuccini and colleagues,18 they found that 
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women with endometriosis (n=161) were more likely to be born with low birth weight and 
prematurely compared to the control group (n=230) of women who undergo laparoscopy but 
not endometriosis related. However, in this study birth characteristics were only 
retrospectively collected through self-reported questionnaires, thus recall bias cannot be ruled 
out. Another case-control study based on 368 women with endometriosis and 375 patients 
without showed that lower birth weight was associated with endometriosis.19 An advantage of 
this study is that birth weights were obtained from medical records, but information on 
women’s gestational age was not available, which limits their ability to investigate whether 
the negative effect from low birth weight on endometriosis is caused by intrauterine growth 
restriction or through preterm birth.  
In line with these studies, a large population-based cohort study of U.S. nurses showed that 
the incidence of endometriosis diagnosis was higher among women with lower birth weight, 
and it was not due to premature birth or multiple fetal gestation.20 However, both birth weight 
and incidence of endometriosis were based on self-reported information, as such, birth weight 
was only investigated in broad pre-specified categories and time for endometriosis diagnosis 
was unclear.  
There are, nevertheless, many studies which failed to find evidence of the relationship 
between in utero exposures and later risk of endometriosis.21, 22,24 For example, in a case-
control study of 91 endometriosis patients and 82 controls, none of the tested in utero 
exposures including birth weight showed significant association with endometriosis.21 
Interestingly, this study has similar study design and sample as the study mentioned before by 
Vannuccini and colleagues, which reported an inverse association between birth weight and 
endometriosis.18  
The inconsistency perhaps results from the reliance on self-reported information on perinatal 
factors, as such findings of these observational studies presumably suffered from recall bias 
considering the long-term gap between in utero exposures and adult endometriosis. Taken 
together, there is no firm conclusion on the developmental origins of endometriosis, 
particularly as many previous studies have methodologic drawbacks, such as self-reported 
birth information, small samples, and cross-sectional design.  
Maternal smoking 
Exposure to an environmental insult during the critical period of life is believed to bring a 
potential negative impact on fetal growth and development, which in turn could permanently 
programme adult health.17 Studies linking maternal smoking and adult onset of endometriosis 
are scanty and yielded conflicting evidence. An Italian case-control study found that mothers 
of endometriosis patients were more likely to smoke during pregnancy, which suggests a risk 
effect from the hazards of tobacco on the development of endometriosis.18 By contrast, a 
cohort study showed that in utero exposure to cigarette smoking was associated with a 
decreased risk of endometriosis, and the inverse association remained given the absence of 
current smoking.23 This finding is however debatable due to the small sample, self-reported 
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maternal smoking behavior, and residual confounding. Likewise, there are two case-control 
studies (91 and 310 cases, respectively)21,22 and one matched cohort study (190 cases)24 that 
found no association between maternal smoking and endometriosis risk.  
Nonetheless, earlier studies in animals and humans have shown that exposure to dioxin was 
associated with elevated risk of endometriosis because of the impaired immune function.65,66 
It thus reasonable to hypothesize that there might be an adverse effect from exposure to 
dioxin and other toxic components from cigarettes in utero. Taking advantage of the Swedish 
national registers with prospective data on maternal smoking and endometriosis, this thesis 
aims to reinvestigate this important aspect of the developmental origins of endometriosis.  
2.2.4 Social and health determinants of endometriosis 
Sociodemographic factors 
Some earlier studies from North America have shown that incidence of endometriosis was 
higher among women with higher educational level.67,68 By contrast, findings from the 
Nordic countries did not show any associations of endometriosis with women’s adult 
education or income.51,69  
Regarding the association between endometriosis and country of origin, an U.S. study among 
parous women has found that endometriosis was more prevalent among women with Asian 
origin compared to Caucasian women.70 However, this finding was not replicated in the 
Nurses’ Health Study II, a large cohort study also from the U.S.71 Further, a Swedish study 
has shown that women who came from Asian countries were at elevated risk of 
hospitalization for endometriosis compared to Swedish-born women.72 In addition to possible 
biological differences, potential underlying causes for the association between country of 
origin and endometriosis are presumably multifactorial. In this thesis, we are interested in 
testing the association with endometriosis by using mother’s country of origin.  
Older maternal age at birth has been suggested to be associated with a decreased risk of 
endometriosis in a prospective cohort study of French women,73 while no association was 
detected in another case-control study.21 Association of maternal reproductive related factors 
with daughter’s endometriosis may not exhibit a causal relationship but rather explained by 
unmeasured confounders, such as maternal endometriosis or mental health.51,74 Thus family-
based designs with ability to account for shared genetic and familial environmental factors 
are required to evaluate the robustness of evidence, which is also an important aim of this 
thesis.    
Reproductive history 
There is consistent evidence showing that endometriosis is inversely associated with number 
of pregnancies.51,68,75,76 In addition, history of infertility was also consistently found 
associated with higher risk of endometriosis.51,67 These results point in the same direction as 
the proposed retrograde menstruation theory of endometriosis (described in section 2.2.2). 
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However, age at first or last birth was less associated with risk of endometriosis.51,75 In 
contrast to endometriosis outside the uterus, uterine adenomyosis (i.e., a special condition of 
endometriosis where the endometrial tissue abnormally located within the myometrial layer 
of the uterus) is more likely to be found among multiparous women.76 77 
Endometriosis and mental disorders 
From a life course perspective, the risk of a disease is affected by a range of biological, 
behavioral and psychosocial processes operating across individuals’ life spans.29 Thus, 
beyond the influence from “fetal programming”, the onset and progression of a chronic 
disease in adult life could also be affected by previous behaviors, physical and psychological 
health.49 Because of the nature of endometriosis, such as chronic inflammatory state, 
incurable condition, adverse consequences on reproductive and physical health, 
endometriosis has been frequently linked to impaired psychosocial well-being and decreased 
health-related quality of life among women with the disorder.10,78 As such, recent review 
studies have explored the role of psychological factors in the progression and management of 
endometriosis.25,26 These studies showed that women with endometriosis are at increased risk 
of psychiatric disturbances, such as anxiety and depressive disorders. On the other hand, 
these psychiatric profiles may affect the severity of endometriosis symptoms, for example, 
through amplifying perceived pain.  
Nevertheless, studies regarding the associations of endometriosis with anxiety and depressive 
disorders were mainly based on small samples (range, 14-166 cases).25,26 Additionally, firm 
conclusions are precluded due to common methodologic limitations embedded in these 
studies, including retrospective and cross-sectional designs,79-81 residual confounding,82 and 
unclear timing of onset or diagnosis of the disorders.83-85 Only one population-based study so 
far has assessed the prospective association between diagnoses of endometriosis and mood 
disorders, but study subjects were only followed for two years, which is too short to fully 
disentangle the temporal association between these disorders.82   
Furthermore, the potential association between endometriosis and bipolar disorder has been 
suggested since the late 1980s.86 But evidence so far is inconsistent and mainly based on 
small clinical studies.86-88 These studies along with other clinical observations, however, 
suggest that there might be a broader comorbidity between endometriosis and mental 
disorders,79,86,89 while, no population-based study so far has explored the associations of 
endometriosis with all mental disorders while taking the timing of the diagnoses into account.   
Considering the heritable nature of endometriosis and mental disorders, any observed 
associations between these disorders might be spurious as they could be explained by 
unmeasured confounding factors, such as genetic susceptibility and other environmental 
factors. Thus, family-based designs by e.g., comparing the risk of a psychiatric disorder 
between biological sisters with and without endometriosis may help reveal part of the 
underlying mechanism from, for example, family liability.   
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2.3 PERIMENOPAUSAL DISORDERS 
Perimenopausal disorders (PDs) are a group of bothersome symptoms found in women’s mid 
to late adult life, marking for the end of the reproductive period. Symptoms of PD include 
vasomotor, psychological, somatic, and vaginal symptoms.5,6,90 Potential causes of these 
symptoms are genetic susceptibility, variations in reproductive hormone levels, lost ovarian 
function, and gynecological lesions.3,4,6 The International Classification of Diseases defines 
PDs into three main subtypes: menopausal and climacteric states (e.g., hot flushes, 
sleeplessness, poor concentration, associated with menopause); perimenopausal bleeding (i.e., 
abnormal vaginal bleeding during peri- and postmenopausal period) and other PDs (e.g., 
senile vaginitis). It is estimated that around 80% of postmenopausal women have experienced 
PDs, while approximately 10% of women with symptoms need to seek health care and 
potentially get diagnosed and treated.91   
Earlier studies on the predictors for the occurrence or severity of PDs were mainly focused on 
adult factors. Consistent evidence suggests that smoking,92-97 alcohol consumption,93,96 less 
physical activity,92-94 menopausal status,90,92,95,98 mental illness,92,93,95 and low socioeconomic 
positions90,92-94,96 are risk factors for perimenopausal symptoms/disorders. Findings on the 
association between adult weight/body mass index and menopausal symptoms are mixed. 
This inconsistency is mainly driven by the variation in study subjects’ menopausal status in 
different studies.99,100 
The developmental origins of menopause-related disorders were only assessed with regard to 
age at menopause. Some studies found that higher birth weight or extremes of birth weight 
were associated with earlier menopause,27,28 which suggests developmental origins of ovarian 
ageing. Nevertheless, no study so far has explored the effect of birth characteristics on the 
occurrence of symptoms/disorders in perimenopausal period. The lack of investigation may 
partially be due to few existing longitudinal data sources containing prospective information 




3 AIM AND RESEARCH QUESTIONS  
This thesis applies the life course perspective to explore the developmental origins and the 
social determinants of ill-health among women. The overarching aim is to investigate a range 
of early life physiological, socioeconomic, demographic, and mental exposures of major 
female hormone-related disorders during reproductive period and menopause, namely, 
endometriosis and perimenopausal disorders (PDs).  
The specific research questions for each study included in the thesis are: 
I: To explore the associations of birth characteristics as well as parental and adult 
socioeconomic and reproductive factors with endometriosis. (Study I) 
II: To explore the perinatal determinants of endometriosis, with specific focus on maternal 
and birth characteristics. (Study II) 
III: To investigate the bi-directional associations of endometriosis with a broad spectrum of 
psychiatric disorders, as well as the role of familial confounding. (Study III) 
IV: To investigate the developmental origins of three subtypes of PDs, including menopausal 
and climacteric states, perimenopausal bleeding, and other PDs (e.g., atrophic vaginitis). 
(Study IV) 
 





4 DATA SOURCE AND MEASURES 
This thesis is based on three register-based longitudinal studies created by linkage of 
routinely collected population-based registers, containing demographic, socioeconomic, 
medical and other information for the population of Sweden. Descriptions of these population 
and health registers along with register linkage studies are presented in detail below.  
4.1 SWEDISH POPULATION AND HEALTH REGISTERS 
Total Population Register  
The Total Population Register (TPR) contains annually collected data on the Swedish 
residents since 1968.101 The TPR was used in this thesis to define the study population, and it 
also provided a range of sociodemographic characteristics for the study population, such as 
sex, year and month of birth, country and county of birth, date of death, date of immigration 
and date of emigration.  
Multi-Generation Register 
The Multi-Generation Register (MGR) includes information on familial relations for the 
Swedish residents who were born in 1932 or later and registered in Sweden at any time since 
1961.102 In this thesis, the MGR was used to identify the study population in Studies I and IV. 
It was also used to extract information on reproduction-related factors (e.g., number of live 
births, age at childbirth), and to define familial relationship (i.e., identify maternal siblings).  
National Patient Register 
The National Patient Register (NPR) contains data for public and private hospital discharges 
since 1964 (psychiatric diagnoses since 1973) and public and publicly funded specialized 
outpatient care since 2001.103 The inpatient register has nearly complete nationwide coverage 
since 1987 (>99%), while the coverage for outpatient register is relative low (80%). The 
Swedish versions of the International Classification of Diseases Eighth (ICD-8, for the years 
1968-1986), Ninth (ICD-9, for the years 1987–1996), and Tenth Revision (ICD-10, from 
1997 onwards) codes were used to identify diagnoses recorded in the NPR.  
Medical Birth Register 
The Medical Birth Register (MBR) provides information on prenatal, delivery, and neonatal 
period for around 98% of mothers and their newborn in Sweden since 1973. Data used in this 
thesis include maternal parity, age at childbirth, and smoking during pregnancy (available 
since 1982), as well as the newborn’s multiple birth status, birth weight, and gestational age. 
In Study II, the MBR was also used to identify familial relationships for the study population 
including biological mother and maternal siblings.  
Archived obstetric records 
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Archived obstetric records were used to extract birth related information for our study 
population who were born before the start of the MBR. The records provide information on 
various maternal and newborn’s characteristics.  
Longitudinal integrated database for health insurance and labor market studies  
The longitudinal integrated database for health insurance and labor market studies (LISA) 
contains annual data on registered adult Swedish residents (aged ≥16 years) since 1990 (since 
2010, aged ≥15 years).104 This thesis uses LISA to obtain information on education, 
occupation, and income. 
Census 
Censuses 1960-1990 were used in this thesis to provide information on study population’s 
educational attainment, occupation, and income.  
4.2 REGISTER LINKAGE STUDIES   
This thesis uses data from three register linkage studies, that were created by merging 
relevant information from population-based registers described above. The linkage can be 
done by using the unique personal identification number that has been assigned to each 
Swedish resident on a permanent basis and remains unchanged throughout the lifetime.105 
The linkage of registers was however deidentified (i.e., without any personal identification 
numbers for the study participants).  
4.2.1 Uppsala Birth Cohort Multigenerational Study 
The Uppsala Birth Cohort Multigenerational Study (UBCoS Multigen) is a representative and 
well-defined cohort of 14,192 males and females born in Uppsala University Hospital during 
the period of 1915-1929,106 that has been combined with social and health data on all their 
descendants, obtained through Swedish routine registers.107 This thesis is mainly based on the 
second generation female offspring who were born between 1933 and 1972.  Considering that 
the majority of the study sample has social and health information recorded earlier than the 
start of the national registers, additional data was obtained from obstetric records and records 
from censuses. The UBCoS Multigen applies the life course approach to investigate early life 
determinants of heath and health inequalities in later life and across generations. 
4.2.2 Swedish Interdisciplinary Panel  
The Swedish Interdisciplinary Panel (SIP) is a longitudinal dataset comprised of several 
Swedish population and health registers. It contains detailed demographic, socioeconomic 
and health data for the total Swedish population born in 1973-1995, as well as their parents 
born outside the main sampling window.108 This thesis uses SIP to explore the perinatal 
sociodemographic and health determinants of endometriosis among women born in Sweden 




4.2.3 Psychiatry Sweden  
‘Psychiatry Sweden’ (PS) is a population-based register linkage created by merging several 
national and local registers in Sweden. The database contains routinely collected longitudinal 
sociodemographic and health data on the entire Swedish population born in 1932-2011 and 
their descendants. The PS is designed for exploring research questions concerning the 
occurrence, predictors, and consequences of mental disorders. 
4.3 ETHICAL CONSIDERATIONS 
Studies I and IV are based on the UBCoS Multigen study. During the establishment of the 
study, information regarding utilizing and analyzing the data have been announced through 
newspapers. The UBCoS Multigen study was created as a linkage of register data without any 
personal identification numbers by the Statistics Sweden and data is stored at the Department 
of Public Health Sciences, Stockholm University. Analytical datasets only contain relevant 
variables for the respective study subjects. The study was approved by the Regional Ethics 
Committee in Stockholm, Sweden (dnrs: 03-117, 04-944T, 2009/1115-32, 2009/1830-32, 
2014/2058-31/5, and 2016/715-32). 
Studies II and III are based on two nationwide register linkage studies, namely the SIP and 
the PS. Requirement for informed consent was waived because these data sources were based 
on register data and study participants were deidentified. SIP was approved by the Regional 
Ethics Committee in Lund, Sweden (dnr: 2012/627). The data is stored and only accessible 
through Statistics Sweden’s Microdata Online Access system. PS was approved by the 
Regional Ethics Committee in Stockholm, Sweden (dnrs: 2010/1185-31/5 and 2016/987-32). 
My analytical datasets only contain relevant variables to investigate the research questions 
and are stored in a KI server.  
Epidemiological research in Sweden greatly benefits from availability of administrative 
(register) data and the unique personal identification number which enables comprehensive 
register-based data linkages. Although research databases are constructed as deidentified, 
potential ethical risks still exist. For example, epidemiological studies usually include various 
socioeconomic and health characteristics of the study participants, and the combination of 
these variables might result in potential identification of a specific person. The risk is 
particularly high for individuals who have extreme values on certain variables or suffered 
from a rare disease. It is therefore important that access to the data is strictly restricted to 
researchers who are in charge of the data analysis, and study findings are only reported at 
group level.  
In addition, the goal of epidemiological studies is to benefit people who struggle with adverse 
health outcomes instead of stigmatizing any specific groups of people. For instances, the 
association between low birth weight and risk of endometriosis should not be treated as a 
reason to blame the mother. It is an integrated result of a wide range of socioeconomic, 
educational, cultural, and familial influences. Also, the comorbid condition between 
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endometriosis and several psychiatric disorders does not mean all woman with endometriosis 
necessarily suffered from mental illness, or vice versa.  
One of the research aims of life course epidemiology is through exploring early life 
predictors/modifiable factors to identify high risk groups and therefore enable more effective 
preventive interventions. To this end, we have published our results in open science and 
carefully reported and interpreted our findings both in the research papers and when 
communicating in media. For example, the psychiatric comorbidity among women with 
endometriosis should be considered as a need to treat women with endometriosis from a 
multidisciplinary approach and a scientific evidence to promote timely diagnosis of both 
disorders. It is believed that a careful dissemination of study results to the public, patients, 
and health professionals benefit population health and outweigh the potential ethical risks. 
4.4 MAIN MEASUREMENTS 
Table 4.4 summarizes the register linkage, data sources, and main measurements used in each 
study. Descriptions of the main measurements are presented in detail below.  
Table 4.4 Summary of register linkage, data sources, and main measurements used in each 
study included in the thesis. 
Study Register 
linkage 
Data sources Main measurements 
I UBCoS 
Multigen 
Archived obstetric records Exposure: birth weight, gestational age 
MGR Parental age at birth 
Index women’s number of live births, age at 
first and last birth 
Census 1960 Family socioeconomic position 
Census 1960, 1970, 1990, LISA Index women’s adult education, income 
NPR Mother’s endometriosis, index women’s 
infertility 
Outcome: Index women’s endometriosis 
II SIP LISA Exposure: maternal education 
MBR Maternal parity, age at birth, smoking during 
pregnancy 
Index women’s birth weight, gestational age 
TPR Maternal country of origin, length of stay 
Index women’s birth county 
NPR Mother’s endometriosis 
Outcome: Index women’s endometriosis 
III PS NPR Exposure & Outcome: endometriosis, 
psychiatric disorders 
MBR Covariate: Maternal age at birth 
Index women’s multiple birth status, birth 
weight 
TPR Birth county 
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LISA Adult education 
IV UBCoS 
Multigen 
Archived obstetric records Exposure: birth weight, gestational age 
Covariate: maternal age, marital status, parity 
  Census 1960, 1970, 1990, LISA Parental education 
  NPR Outcome: perimenopausal disorders 
4.4.1 Birth characteristics (all studies) 
Birth weight 
Birth weight in kilograms was classified into four categories, slightly different cut-points 
were used with consideration of sample distribution in each study. In Studies I and IV based 
on the UBCoS Multigen study, birth weight was classified as <3.0, 3.0-3.4, 3.5-3.9, ≥4.0 kg; 
in Studies II and III based on the total Swedish population, it was classified as <2.5, 2.5-3.4, 
3.5-4.4, ≥4.5 kg. 
Gestational age 
Gestational age was measured as length of gestation in completed weeks. The estimation is 
based on either mother’s self-reported first date of the last menstrual period or ultrasound 
examination. It was categorized as preterm birth (<37 weeks), full term (37-41 weeks), and 
post term (≥42 weeks). 
Birth weight-for-gestational age 
In Studies I and II, we focused on the effect of birth weight relative to gestational age, which 
is an indicator for fetal growth rate. It was created by standardizing birth weight by week of 
gestation, using the total Swedish female births as the reference (birth years 1973-1998 for 
Study I, 1973-1987 for Study II).  
Other birth characteristics included in the thesis were birth county within Sweden (eastern, 
southern, northern Sweden), and multiple birth status (singleton, twins or more).  
4.4.2 Parental characteristics (all studies) 
Parental/maternal education was measured as the highest recorded educational level of either 
parent/the mother, and classified into elementary, secondary, shorter post-secondary, and 
university education. Family socioeconomic position (SEP) was based on the father’s 
occupation, or the mother’s occupation if the information was missing in the father. SEP was 
categorized as high, intermediate, and low. Other sociodemographic information including 
maternal and paternal age at childbirth (<20, 20-34, ≥35 years for the mothers, <25, 25-35, 
≥36 years for the fathers), maternal marital status, and parity. Mother’s region of birth was 
based on country of origin and classified according to countries similarities with respect to 
socio-cultural context. For the foreign-born mothers, length of stay in Sweden was calculated. 
Maternal smoking during pregnancy was prospectively recorded at mothers’ first visit of 
antenatal care, usually during the first trimester.109 This information is available for a 
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subgroup of index women who were born in 1982-1987 (Study II).  Ascertainment for 
maternal endometriosis was same as for the index women which will be described in detail in 
section 4.4.4.  
4.4.3 Adult characteristics (all studies) 
Women’s adult socioeconomic characteristics were highest achieved education and income. 
Reproduction-related factors including number of liveborn children, infertility history 
(diagnostic codes: ICD-7 636, ICD-8 628, ICD-9 628, and ICD-10 N97), as well as age at 
first and last childbirth.  
4.4.4 Endometriosis (studies I, II, & III) 
Endometriosis cases were identified as having a main or contributory diagnosis in the NPR 
during the respective follow-up period. Using the ICD, any endometriosis was defined as the 
ectopic presence of endometrial-type tissue at any site (ICD-8 code 625.3, ICD-9 code 617, 
and ICD-10 code N80).  
In studies I and III, two endometriosis subtypes were further distinguished based on the 
presence of endometrial tissue outside or within the uterus, namely, external endometriosis 
(i.e., outside the uterus) using codes 625.30–625.32, 625.38, 625.39 (ICD-8), 617.B-617.X 
(ICD-9), N80.1-N80.9 (ICD-10); and uterine adenomyosis using codes 625.33 (ICD-8), 
617.A (ICD-9), and N80.0 (ICD-10). In the analyses for subtypes, cases were identified as 
women having a first recorded respective subtype during the follow-up period (e.g., a woman 
does not get censored for external endometriosis if she has been diagnosed with adenomyosis 
previously).  
A previous validation study has reported a positive predictive value of 97.8% for 
endometriosis cases recorded in the inpatient register, based on comparing with the respective 
patients’ medical records.103   
4.4.5 Psychiatric disorders (study III) 
Study III aims to study the associations of endometriosis with a board spectrum of psychiatric 
disorders, nine groups of psychiatric disorders were considered. Cases were ascertained as 
having a diagnosis of the specific disorder in the NPR using the respective ICD codes listed 
in Table 4.4.5. Women were allowed to be classified as cases for more than one type of 
psychiatric disorder. 
Table 4.4.5 ICD codes for diagnoses of psychiatric disorders. 
Psychiatric disorders ICD-9 ICD-10  
Non-affective psychotic disorders 295 (excluding 295H), 
297, 298 (excl. 298B) 
F20-24, F28, F29 
 
Bipolar and other affective psychotic 
disorders 
296, 295H, 298B F25, F30, F31, F32.3, F33.3 
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Depressive disorders (excluding those 
with psychotic symptoms) 
300E, 311 
 
F32 (excl. F32.3), F33 (excl. 
F33.3), F34, F38, F39 
Anxiety and stress related disorders 
 
300A-D, 300F, 300G, 
300H, 300W, 300X, 306, 
307A, 308, 309 
F40-45, F48 
Eating disorders 307B, 307F F50 
Alcohol/drug dependence disorders 291, 292, 303, 304 F10-16, F18, F19 (all 
exclude 4th digit .0 and .9) 
Personality disorders 301 F60-63, F68, F69 
Autism spectrum disorder 299A, 299B, 299W F84.0-F84.5 
Attention-deficit hyperactivity disorder 314 F90 
4.4.6 Perimenopausal disorders (study IV) 
Cases of perimenopausal disorders (PDs) were identified as the first recorded main or 
contributory diagnosis registered in the NPR at any time between 2001 and 2008. Using the 
ICD-10, PDs were classified into three subtypes: menopausal and climacteric states (code 
N95.1), perimenopausal bleeding (codes N92.4 and N95.0), and other PDs (codes N95.2, 
N95.8, and N95.9; e.g., atrophic vaginitis). We studied these subtypes of PDs separately in 
order to assess whether the potential developmental origins effect varies by the type of 
disorder. Therefore, women were allowed to be classified as cases for more than one subtype 
(e.g., a woman diagnosed with both perimenopausal bleeding and other PDs will be included 
both in the separate analyses for perimenopausal bleeding and other PDs). As such, incidence 
cases for each subtype were calculated from first recorded diagnosis for the specific disorder 
during the follow-up. It should be noted that to ensure these disorders are the results of 
natural menopause, women with a hysterectomy and oophorectomy were excluded or 
censored in the sensitivity analysis, defining these procedures through the Swedish 
Classification of Operations and Major Procedures (diagnostic codes: 7210, 7211, 7261, 
7262, 7467, LCD00-04, LCC10, LCD10, LCD11, LEF13).110 Also, women who diagnosed 





5 STATISTICAL METHODS 
5.1 SURVIVAL ANALYSIS 
Survival analysis is a statistical technique to analyze time to event data. Since all the studies 
included in the thesis are based on longitudinal data and interested in time at diagnosis of a 
disease, survival analysis was used in all studies. In the analysis, individuals are followed 
from the time of origin, until an event of interest, events of censoring, or the end of the 
follow-up, whichever came first. Individuals may drop out from the study before 
experiencing the event of interest, due to emigration or death for instances; they could also 
stay event free at the end of the follow-up, these are right censored. Depending on the 
research question or time of origin, a timescale should be decided prior to the analysis, e.g., 
attainted age or time since diagnosis. In this thesis, age was chosen as the underlying 
timescale.  
5.1.1 Survival analysis with time-dependent effect 
The proportional hazards assumption is a strong assumption in Cox regression. It ensures the 
relative hazard is constant over follow-up time. There are several tests that can be utilized to 
assess the appropriateness of the proportional hazards. In this thesis, the assumption was 
tested through the Schoenfeld residuals method. If there is evidence of non-proportionality in 
the model, supplementary or alternative methods would be performed to model the 
interaction of an exposure with the underlying timescale.   
In Study I, we detected that the proportional hazards assumption was violated for the 
association between our primary exposure (i.e., between birth weight-for-gestational age) and 
the outcome of interest (i.e., endometriosis). Thus, an alternative method, the flexible 
parametric survival model was applied to estimate the time-dependent effect of the exposure 
with regard to the underlying timescale (i.e., age at diagnosis of endometriosis).111 In addition 
to estimate the regression coefficients as in the Cox model, the flexible parametric survival 
model estimates the baseline hazard (on the log hazard scale) and allows for interaction 
between the exposure and the underlying timescale.  
In the flexible parametric survival model, the baseline hazard is plotted by the restricted cubic 
splines.112 The splines consist of piecewise cubic polynomials joined through points called 
knots.113 These knots together with some constraints (which restrict the fitted function to be 
linear outside the boundary knots) can ensure that the shape of the baseline hazard is 
smooth.112 As such, the model could estimate the variations in hazard ratio over time. The 
number of knots is based on degree of freedom, which can be selected from an information 
criterion.114 Since the hazard ratio is not constant over follow-up time, the flexible parametric 
survival model often presents the non-proportional (time-dependent) effect graphically.  
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5.1.2 Survival analysis with time-dependent exposure 
Time-dependent exposure/covariate refers to when the status of an exposure/covariate 
changes over follow-up time, instead of being recorded before or at the start of the follow-up. 
It could be analyzed within the Cox proportional hazards regression model. Taking advantage 
of the prospectively collected longitudinal patient data, Study III explored the bi-directional 
temporal associations between endometriosis and psychiatric disorders. In this study, the 
exposure is the first diagnosis of the exposure disorder. The exposed time was calculated 
differently under three main scenarios: 1) if the woman was exposed before the start of the 
follow-up, the exposed time would be between the start and the end of the follow-up; 2) if the 
woman was exposed after the start of the follow-up, the exposed time would be between the 
time of first diagnosis of the exposure and the end of the follow-up, in other words, the 
woman would be treated as late entry at time of the exposure disorder; 3) if the woman was 
exposed after any censoring events (i.e., outcome occurs, death, emigration, or end of the 
follow-up), the exposed time would be considered as none. 
5.2 ASSESSING UNMEASURED CONFOUNDING  
Causation is a primary goal for epidemiological studies, as it will provide information on e.g., 
whether a disease can be prevented through modification of a certain exposure. 
Counterfactual-based approach to causal inference suggests that the causal effect of an 
exposure (or treatment) can only be estimated by comparing the potential outcomes from two 
hypothetical worlds: if everyone had been exposed and if everyone had not been exposed.115 
Since these two counterfactual scenarios can never be observed simultaneously in reality, an 
alternative is to assign individuals to be exposed and unexposed completely at random. In the 
absence of such ideal randomized experiments (commonly due to ethical and practical 
reasons), causal inference is usually made under conditional exchangeability in observational 
data through, among others, controlling for confounding. In an attempt to understand the 
causal nature of any observed associations, assessment for unmeasured confounding is one of 
the main issues to concern.   
5.2.1 Family-based designs 
One conventional way of controlling for confounding is through statistical modelling when 
measured early life factors that are the common causes of the exposure and the outcome are 
adjusted in the regression analysis. Nevertheless, the observed association could still be 
biased by unmeasured factors (e.g., genetic and other familial environmental factors) and thus 
spurious. As such, the observed association may be neither informative to causal 
interpretation nor relevant to public health prevention. To this end, family-based designs 
might provide an opportunity to address causality questions when randomized controlled 
trials are not practical.29  
One commonly used family-based design is sibling comparison, where the effect of an 
exposure could be examined between individuals who were discordant for exposure status but 
raised in the same family and are genetically similar.116 The result from a sibling comparison 
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model with adjustment for measured confounders would produce an informative estimate for 
the exposure-outcome association, in which measured confounders and unmeasured genetic 
or familial environmental factors shared by the siblings would be taken into account.  
Study II applied a within-family comparison method to assess whether the observed 
associations at population level were confounded by residual confounding in analyses of 
exposures that vary between sisters. To do this, a “between-mother” variable was created to 
represent the average value of the exposure of interest within each family (clustered in 
mother); and a “within-mother” variable to represent the departure of each study subject from 
the family average value. These two variables were then fitted in the Cox regression model 
together with other measured confounders. To test residual confounding, Wald test was 
preformed to examine whether the estimated between-mother effect equals to the within-
mother effect. If these two effects were statistically significantly different from each other, 
we interpreted these as evidence of residual familial confounding. This method was originally 
proposed and applied by Mann et al.117 
Study III utilized a fixed-effect regression method with clustering on the families to account 
for residual familial confounding.118 Specifically, the bi-directional associations between 
endometriosis and psychiatric disorders were estimated in the stratified Cox regression 
among families with at least two female children. By conditioning on family (clustered in 
mother), the model could automatically account for family-constant factors that were shared 
by the sisters, such as early childhood environment, parenting, or their genetic makeup. To 
further quantify the residual familial confounding, the effect of endometriosis on psychiatric 
disorders was tested by using the sister’s endometriosis status among women without 
endometriosis. If the association was statistically significant, we interpreted such association 
as likely driven by shared familial liability.    
5.2.2 E-value measure 
E-value measure is a statistical tool commonly used in sensitivity analysis, which could 
assess how robust the observed associations are to unmeasured confounding. It can be used as 
a supplementary or alternative measure of family-based designs. This is because, first, 
family-based designs could still suffer from unmeasured non-shared confounding, and 
second, family-based designs require large sample size and detailed information on familial 
relations and, also, they may not be informative to explore the effect of family-constant 
exposures. Due to these reasons, E-value measure was used in Studies I and II to assess 
residual confounding. The E-value is defined as conditioning on measured confounders, how 
much unmeasured confounding would need to be associated with both the exposure and the 
outcome on the risk ratio scale that could fully explain away the observed effect or move the 
confidence interval to include null, but weaker confounding would not.119 The method was 
originally proposed by VanderWeele and Ding.119  
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5.3 COUNTERFACTUAL-BASED MEDIATION ANALYSIS 
Mediation analysis is commonly used in life course epidemiology, which could help identify 
mechanisms that explain the association between an early life exposure and an adult health 
outcome. Counterfactual-based mediation analysis is used in Studies I and II to decompose 
the total effect into direct effect (i.e., effect from the exposure independent from the 
examined mediators) and indirect effect (i.e., effect from the exposure explained through the 
examined mediators). The identification of counterfactual-based mediation effect is achieved 
under several assumptions, including no interference, consistency, and conditional 
exchangeability. One important assumption that needs to be carefully considered during study 
design and data analysis is the conditional exchangeability, which states that there should be 
no further confounding of the exposure-outcome, exposure-mediator, and mediator-outcome 
associations, conditional on measured confounders.120  
In comparison to the traditional approach, the counterfactual approach to mediation analysis 
could accurately decompose the total effect into natural direct and indirect effects, as well as 
estimate the controlled direct effect in the presence of exposure-mediator interaction or 
intermediate confounding (i.e., confounder of the mediator-outcome association while 
affected by the exposure).121,122 This thesis applied the g-computation procedure (gformula in 
Stata) to perform the counterfactual-based mediation analysis.123 For causal conclusions, this 
method relies on all the aforementioned assumptions and inclusion of the exposure-mediator 





6 STUDY SUMMARIES  
6.1 STUDY I 
6.1.1 Study population 
Study I explored the associations of birth and early life characteristics with incidence of two 
subtypes of endometriosis. The study population was based on the second female generation 
of the UBCoS Multigen who were born between 1933 and 1972 with traceable birth records. 
Of 3476 women, we excluded 54 with multiple birth status, and 16 who had died or 
emigrated before the start of follow-up. The final analytical sample included 3406 women.  
6.1.2 Design and statistical analysis 
Cox regression was used with robust standard errors (SEs) to account for potential 
correlations between women born to the same mother. Women were followed from 15 years 
of age, or January 1, 1968, whichever came later. The follow-up continued until 50 years of 
age, or December 31, 2008, or death, emigration, or first diagnosis of the endometriosis 
subtype in question, whichever came earlier. All models were first adjusted for year of birth 
to account for potential period effect, and then earlier life confounding factors for the 
explanatory variable in question were additionally included in the model. Earlier life 
confounders were chosen separately for sets of explanatory variables that occurred at 
different life stages (i.e., birth, perinatal, and adult period). Birth weight-for-gestational age 
and gestational age were mutually adjusted in all models, to distinguish the effects of being 
born earlier versus slow fetal growth trajectory. Considering the small number of cases for 
adenomyosis, it was modelled only with the adjustment for birth year.   
Mediation analysis was conducted to examine the role of index women’s adult characteristic 
(i.e., number of live birth) with respect to the total association between birth weight-for-
gestational age and endometriosis.  
Since the proportional hazards assumption was violated for the association between between 
birth weight-for-gestational age and endometriosis, it was further examined through the 
flexible parametric survival model to estimate and plot the time-dependent effect of between 
birth weight-for-gestational age on endometriosis over follow-up time. The E-value measure 
was used to assess the robustness of the total association with respect to unmeasured 
confounding.  
6.1.3 Results 
In the analytical sample, 111 (3.3%) women have received an endometriosis diagnosis, 
corresponding to an incidence rate (IR) of 1.08 per 1000 woman-years. There were two peaks 
in the incidence of any endometriosis, the early peak was around age 25 and predominantly 
contributed by external endometriosis cases. The later peak was around age 45 consisted by 




Figure 6.1.3.A Incidence rate of first diagnosis with (A) any endometriosis (n=111), (B) 
external endometriosis (n=91), and (C) uterine adenomyosis (n=24). Note: Figure 1 in Study I.  
Associations with birth and perinatal characteristics  
Figure 6.1.3.B shows the time-dependent effect of birth weight-for-gestational age on any 
endometriosis. On average, lower birth weight-for-gestational age was associated with 
increased incidence of any endometriosis. The association was attenuated when 
endometriosis was diagnosed at later reproductive life, the stage when half of the cases were 
adenomyosis. This points to the same direction as findings of the two subtypes. Specifically, 
birth weight-for-gestational age showed a proportional and inverse association with external 
endometriosis (adjusted hazard ratio [HR], 1.44; 95% confidence interval [CI], 1.13-1.84, per 
SD decrease), but not with adenomyosis. Gestational age, on the other hand, was not 
associated with any type of endometriosis (Figure 6.1.3.C). The E-value measure indicated 
that the association between birth weight-for-gestational age and endometriosis was rather 
robust to unmeasured confounding.  
 
Figure 6.1.3.B Time-dependent association between birth weight-for-gestational age and any 
endometriosis. Note: the black curve shows the ratios between 25th and 75th percentiles of birth 
weight-for-gestational age with adjustment for birth year and gestational age. Grey area shows the 
95% CI. Figure 2 in Study I.  
There was no evidence for associations of family socioeconomic position and maternal age 
with any type of endometriosis. Older paternal age was associated with a lower incidence of 
external endometriosis in the daughter, but not with adenomyosis. Maternal endometriosis 
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history was a strong predictor for daughter’s external endometriosis. Adjustment for other 
perinatal factors makes little change to these associations (Figure 6.1.3.C).  
 
Figure 6.1.3.C Associations of birth, perinatal and adult characteristics with rate of 
endometriosis and its two subtypes (n=3406). Note: SD, standard deviation; SEP, socioeconomic 
position. Estimates for any and external endometriosis adjust for birth year and (other) perinatal 
characteristics; estimates for adenomyosis adjust for birth year; plus birth weight-for-gestational age 
and gestational age were mutually adjusted in all analyses. This figure was based on estimates from 
Table 2 in Study I. 
Associations with adult characteristics 
Neither index women’s adult education nor income was associated with endometriosis. 
Number of live births showed an inverse dose-response association with external 
endometriosis but presented a non-significant opposite trend with adenomyosis. However, 
mediation analysis showed that number of live births could only explain a limited proportion 
of the inverse association of birth weight-for-gestational age with any and external 
endometriosis (4% and 2%, respectively). Women with prior infertility disorder were at 2-
fold increased rate of external endometriosis, but not adenomyosis (Figure 6.1.3.C).    
6.2 STUDY II 
6.2.1 Study population  
Study II investigated the associations of perinatal characteristics with endometriosis in a 
nationwide cohort of women born in Sweden between 1973 and 1987. Starting from 688 412 
singleton women, we excluded 0.8% who died, and 3.4% who emigrated before their 
fifteenth birthdays. A further 5.3% were excluded due to missing information on explanatory 
variables, and a 0.007% were excluded due to implausible combinations of birth weight and 
length of gestation. The final analytical sample included 628 312 singleton women.  
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6.2.2 Design and statistical analysis 
Cox regression with robust SEs was utilized to follow women from their 15 years of age, 
continue until December 31, 2012, or death, emigration, or first diagnosis of endometriosis, 
whichever came earlier. All explanatory variables were first modelled with endometriosis 
with the adjustment for year of birth, measured maternal characteristics were additionally 
adjusted in the final model.  
Within-family comparison was applied to examine whether the observed associations were 
likely the result of unmeasured familial confounding, it was used for the explanatory 
variables that are commonly differed between sisters. For the same aim, E-value was used for 
the explanatory variables that are constant within families. These methods were described in 
detail in sections 5.2.1 and 5.2.2. The potential mediation effect of birthweight-for-gestational 
age in the associations between maternal characteristics and endometriosis was also assessed.  
6.2.3 Results 
Among women aged 15-40 years, 8262 (1.3%) received an endometriosis diagnosis during 
the observation period, corresponding to an age-specific IR of 0.77 per 1000 woman-years.  
Associations with maternal characteristics 
Figure 6.2.3.A shows the associations of maternal characteristics with endometriosis. Higher 
maternal educational level showed a dose-response association with endometriosis, 
specifically, the rate was 16% (95% CI, 9%-22%) lower for women with mothers of 
university degree compared to those born to mothers with elementary education. We found a 
higher incidence of endometriosis among women born to mothers who came from other 
Nordic countries and the former Soviet states, but these associations could not be explained 
by mother’s length of stay in Sweden (data not shown).  
 
Figure 6.2.3.A Associations of maternal characteristics with rate of endometriosis among 
women born in Sweden in 1973-1987. Note: Estimates adjust for birth year and other maternal 
characteristics except for mother’s smoking. Estimates for mother’s smoking were based on a 
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subgroup of women born in 1982-1987 (n=203 891) and adjust for other maternal characteristics. This 
figure was based on estimates from Table 2 in Study II.  
As shown in the right part of Figure 6.2.3.A, higher maternal age was associated with 
decreased incidence of endometriosis in daughters. This association was however attenuated 
to non-significant in the within-mother analysis, suggesting that unmeasured familial 
confounding may account for the association rather than a true causal effect (data not shown). 
Mother’s parity was not related to daughter’s endometriosis. Expectedly, mother’s 
endometriosis history was a strong predictor for the increased incidence of endometriosis in 
daughters. We found maternal smoking during pregnancy predicted a higher incidence of 
early onset of endometriosis in daughters, independent from other measured maternal 
characteristics and unmeasured familial factors shared by the sisters. 
Associations with birth characteristics 
Both the absolute and relative measures 
of birth weight showed independent 
inverse associations with endometriosis. 
Within-family analysis for birth weight-
for-gestational age further indicated no 
evidence of residual familial 
confounding. Mediation analyses showed 
that birth weight-for-gestational age 
could explain 26% of the total 
association between maternal smoking 
and endometriosis. Whereas length of 
gestation was not associated with 
endometriosis. Women born in southern 
Sweden had slightly increased incidence 
of endometriosis compared to those from 
the eastern part. (Figure 6.2.3.B)  
6.3 STUDY III 
6.3.1 Study population 
Study III explored the bi-directional associations between endometriosis and psychiatric 
disorders in a nationwide cohort of all live female births in Sweden between 1973 and 1990. 
Of 893 716 women, we excluded 7555 who died, 31 798 who emigrated, and 2 who received 
an endometriosis diagnosis before their fourteenth birthdays, giving an analytical sample of 
854 361 women. Sibling comparison analysis was conducted in a subsample of 173 650 




6.3.2 Design and statistical analysis 
Cox regression with time-dependent exposure modelling was used to account for women who 
received a diagnosis of the exposure disorder before or during the follow-up. Women were 
followed from 14 years of age until December 31, 2016, or death, emigration, or first 
diagnosis of the outcome disorder in question, whichever came earlier.  
All bi-directional associations were adjusted for women’s year of birth, then measured birth 
characteristics along with women’s educational level were included in the fully adjusted 
model. The main analyses were repeated in a fixed-effect model with clustering on the 
families with at least two female children by using the stratified Cox regression with the 
adjustment for measured confounders. By design, the model is expected to additionally adjust 
for unmeasured familial factors shared by the sisters. To further quantify unmeasured familial 
confounding, logistic regression was used to compare the odds of psychiatric disorders using 
sister’s endometriosis status in a subsample of women without endometriosis. These 
associations were adjusted for birth year and measured confounders.  
For sensitivity analyses, first, our main analyses were repeated separately for two 
endometriosis subtypes to explore whether the observed associations vary by type of 
endometriosis. Second, to partially account for the potential diagnostic delay in both 
endometriosis and psychiatric disorders, we repeated the main analyses by including a six-
month lag time in between the exposure and the outcome disorders.  
6.3.3 Results 
In a nationwide cohort of women aged 14-43 years during the observation period of 1987-
2016, 14 144 (1.7%; IR, 0.84 per 1000 woman-years) of them received an endometriosis 
diagnosis. In this cohort, anxiety and stress-related disorders and depressive disorders were 
the two most prevalent psychiatric disorders, which affect 111 847 (13.1%; IR, 6.91 per 1000 
woman-years) and 79 232 (9.3%; IR, 4.82 per 1000 woman-years) women respectively. The 
age-specific IRs for these two common psychiatric disorders and endometriosis reached peak 
around age 30, whereas most other psychiatric disorders peaked at earlier ages. 
Endometriosis and later diagnosis of psychiatric disorders 
At population level (first column of HRs in Figure 6.3.3.A), after adjustment for birth year, 
birth characteristics, and educational level, women with endometriosis showed increased 
rates of being later diagnosed with all groups of psychiatric disorders, with the exception for 
autism spectrum disorder (ASD). The HRs ranged from 1.93 (95% CI, 1.71-2.18) for 
alcohol/drug dependence disorders to 1.30 (95% CI, 1.00-1.69) for non-affective psychotic 
disorders. In the sibling comparison analyses (second column of HRs in Figure 6.3.3.A), 
compared to unaffected sisters, women with a previous endometriosis remained at higher risk 
of being diagnosed with depressive disorders, anxiety and stress-related disorders, 
alcohol/drug dependence disorders, and attention-deficit hyperactivity disorder (ADHD), 




Figure 6.3.3.A Hazard ratios for diagnosed psychiatric disorders following a diagnosis of 
endometriosis. Note: adjusted HRs were adjusted for birth year, birth characteristics and education; 
same set of factors were adjusted in sibling comparison HRs along with unmeasured familial factors 
shared by the sisters. This figure was based on estimates from Table 2 in Study III.   
Psychiatric disorders and later diagnosis of endometriosis 
The fully adjusted population-level analyses showed that all examined psychiatric disorders 
except for non-affective psychotic disorders were associated with an increased rate of being 
later diagnosed with endometriosis (first column of HRs in Figure 6.3.3.B). The associations 
with alcohol/drug dependence disorders and ASD were attenuated to non-significant when 
unmeasured familial factors were considered through comparing sisters exposed and 
unexposed to the respective psychiatric disorder (second column of HRs in Figure 6.3.3.B).  
 
Figure 6.3.3.B Hazard ratios for diagnosed endometriosis following a diagnosis of 
psychiatric disorder. Note: adjusted HRs were adjusted for birth year, birth characteristics and 
education; same set of factors were adjusted in sibling comparison HRs along with unmeasured 
familial factors shared by the sisters. This figure was based on estimates from Table 3 in Study III.   
In sensitivity analyses restricting to women without a diagnosed endometriosis, having a 
sister with endometriosis was associated with increased odds of being diagnosed with 
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depressive disorders, anxiety and stress related-disorders, personality disorders, and ADHD. 
The analyses of including a six-month lag time in between the exposure and the outcome 
disorders only slightly attenuated the bi-directional associations both in the population-based 
and sibling comparison models (data not shown).   
6.4 STUDY IV 
6.4.1 Study population 
Study IV explored the associations of birth characteristics with three subtypes of 
perimenopausal disorders (PDs). The study population was based on the second female 
generation of the UBCoS Multigen, who were born between 1936 and 1968. Of a total of 
4290 singleton women, we excluded 258 who died or emigrated before the start of follow-up, 
and 820 whose birth records were not available This resulted in a final analytical sample of 
3212 women. There was no statistically significant difference in the incidence of any 
subtypes of PDs between women with available birth records and those without (all P>0.10).  
6.4.2 Design and statistical analysis 
Cox regression with robust SEs was used to estimate the main associations. Follow-up started 
from when women turned 40 years of age, or January 1, 2001, whichever was latest, and 
continued until when they turned 65 years of age, or December 31, 2008, or death, 
emigration, or first diagnosis of the disorder in question, whichever was earliest. The main 
exposures, birth weight and gestational age were modelled as continuous variables, as there 
was no evidence of nonlinearity, when including a quadratic term in the model (all P>0.26). 
Analyses were first adjusted for birth year, and birth weight was additionally adjusted for 
gestational age. Then parental characteristics were further included in the model. In 
sensitivity analysis, to assess the robustness of our study findings with regard to natural 
menopause, we excluded women who had a hysterectomy or oophorectomy from the study 
sample and censored women at these events during the follow-up. All statistical analyses in 
this thesis were performed in Stata versions 14 and 15 (StataCorp). 
6.4.3 Results 
In the analytical sample, 218 women (6.8%) received a PD diagnosis, which included 125 
women diagnosed with menopausal and climacteric states, 61 women with perimenopausal 
bleeding, and 58 women with other PDs (e.g., atrophic vaginitis or other unspecific PDs). 
Incidence of menopausal and climacteric states increased gradually from age 45 to 65, while 
other PDs showed up later from age 50. In contrast, perimenopausal bleeding was 




Figure 6.4.3 Cumulative incidence of first diagnosis with any perimenopausal disorders and 
its three subtypes. Note: Figure 1 in Study IV. 
Women diagnosed with menopausal and climacteric states were more likely to be highly 
educated or born to well-educated parents. Higher maternal parity was related to higher 
incidence of being diagnosed with other PDs. Perimenopausal bleeding disorder was more 
commonly diagnosed among women with more children.  
After adjustment for birth year and gestational age, birth weight was positively associated 
with incidence of menopausal and climacteric states. Specifically, the rate was 66% (95% CI, 
14%-141%) higher per kilogram increase in birth weight. Length of gestation was not 
associated with incidence of menopausal and climacteric states (Table 6.4.3). 
Neither birth weight nor gestational age showed statistically significant association with 
perimenopausal bleeding disorders. Birth weight was not associated with other PDs. Instead, 
rate of other PDs was lower among women born at older gestational age (minimally adjusted 
HR, 0.87; 95% CI, 0.79-0.95). Additional adjustment for parental characteristics did not 
change these results significantly (Table 6.4.3). These findings remained largely similar in the 
sensitivity analysis with censoring for hysterectomy and oophorectomy (data not shown).  















































CI, confidence interval; HR, hazard ratio; PD, perimenopausal disorder. 
a Minimally adjusted models adjust for birth year; birth weight was additionally adjusted for gestational age. 
b Further adjusted models additionally adjust for parental education, mother’s marital status, age, and parity at 
birth. 





7.1 INTERPRETATION AND IMPLICATIONS 
7.1.1 Developmental origins of endometriosis 
In Study I and II, we have investigated the developmental origins effect with respect to 
endometriosis, a common chronic condition affecting women of reproductive age. In study I, 
we were able to follow women’s entire reproductive period and showed that lower birth 
weight relative to gestational age was associated with risk of endometriosis, particularly when 
onset of the disorder occurred during the early to the mid-reproductive period (i.e., between 
ages 15-40 years). This association was further confirmed in Study II by analyzing a 
nationwide cohort of females, although women were relatively younger at the end of follow-
up period (i.e., aged 25-40 years) compared to Study I.  
Our results are consistent with previous studies regarding the inverse association between 
birth weight and endometriosis, and also extend those findings by showing that the effect 
from low birth weight was mainly driven by the slow fetal growth rate rather than being born 
prematurely.18,20,124 Slow fetal growth is a marker for a range of adverse conditions during the 
earliest stage of development, such as fetal malnutrition, alterations in endocrine status, less 
functional capacity of the reproductive organs.17,125 As human beings are sensitive and 
capable of adapting to the environment,14 these harsh early conditions may cause a series of 
responses in the body, such as alterations in hormone secretion or tissue hormone 
sensitivity.17 All of these could contribute to the development of endometriosis, an estrogen-
dependent disease regulated by ovarian steroid production.  
In addition, low birth weight has been linked with impaired function of immune system in 
later life,126 this is crucial as the immune-system dysregulation is one of the sufficient causes 
for endometriosis.60  
Moreover, our studies suggest that the inverse association between birth weight-for-
gestational age and endometriosis was rather robust to familial confounding. This is 
supported by the association remaining the same in both cases: on adjustment for maternal 
endometriosis (in Study I), and in within-family comparisons by controlling for unmeasured 
genetic and familial environmental factors shared by the siblings (in Study II).   
7.1.2 Maternal smoking and risk of endometriosis 
To our best of knowledge, this research is the first prospective study based on the total-
population to investigate the effect of in utero exposure to smoking on endometriosis. A clear 
positive dose-response association was found between maternal smoking during pregnancy 
and daughters’ endometriosis risk during early to mid-reproductive period. The association 
was also confirmed in the within-family analysis, indicating shared familial confounding was 
unlikely to fully explain the increased risk.  
 
36 
Previous findings on the effect of in utero exposure to smoking were conflicting and 
inconclusive, with interpretations limited by the fact that they were based on retrospectively 
collected data on exposure status and relatively low statistical power (range, 32-310 
cases).24,127-129  
Evidence on the effect of adult smoking was rather consistent and suggested a protective 
effect on endometriosis, potential mechanism involve reduced estrogen levels caused by 
smoking.71,130 It is unfortunate that we could not study the effect of adult smoking and its role 
with regard to the association between intrauterine exposure to smoking and endometriosis. 
We however speculate that the mechanism for exposure to smoking in utero is different 
compared to adult direct smoking. It could be that in utero exposure to dioxins or other toxic 
components caused by mother’s smoking decreased the functional capacity of immune 
system in the fetuses and thereby made them susceptible to inflammation and ectopic 
endometrium.131 This speculation is supported by studies on both animals and humans, in 
which environmental exposure to dioxin has been found to increase the risk of endometriosis 
due to impaired immune defense.65,66 In light of this, elevated risk of endometriosis has also 
been found among women who were exposed to passive smoking during childhood.132   
7.1.3 Other parental and adult characteristics with risk of endometriosis 
In this thesis, we also explored whether exposures across life may exert life course or 
intergenerational effects on endometriosis. Specifically, we looked at other maternal or 
paternal health, socioeconomic and demographic characteristics as well as women’s own 
adult characteristics and subsequent risk of endometriosis.  
As expected, we found that mother’s endometriosis history was strongly associated with the 
risk of endometriosis in daughters. This evidence reflects the heritable nature of 
endometriosis, in line with many previous studies.63,133,134 In studies I and II, we have 
identified inverse associations of paternal age and maternal age at birth with daughter’s 
endometriosis at population level. The association with maternal age, however, was found to 
be spurious in the within family comparison through accounting for unmeasured familial 
confounding. The protective effect of higher father’s age on daughter’s endometriosis is 
intriguing but may also suffer from familial confounding. Unfortunately, this thesis was 
unable to further investigate the potential confounding bias and underlying mechanism due to 
unavailability of data, but we will strive to revisit this finding in the future.  
We did not detect any significant associations between index women’s highest education and 
adult income with endometriosis. The lack of association with education has also been shown 
in a Norwegian study,69 however, it is inconsistent with findings from North America where 
excess risk was found among women with higher socioeconomic positions.67,68 We speculate 
that this inconsistency could partially be driven by variation in the ability to access to 
healthcare in different social contexts. In the U.S., for example, poor access to healthcare may 
lead a considerable proportion of undiagnosed cases among women from lower 
socioeconomic positions, which would artificially lower their observed incidence rate. In 
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contrast, the egalitarian healthcare system in Nordic countries ensures women have relatively 
equal access to medical care regardless of their socioeconomic conditions. We additionally 
noticed that the incidence of endometriosis was higher among women born to mothers with 
lower educational level.  
Moreover, we found elevated risk of endometriosis among women who were born to mothers 
who came from other Nordic countries and from the former Soviet states. The higher risk of 
endometriosis for women with mothers originally from other Nordic countries compared to 
Swedish-born mothers is indirectly in agreement with a previous Swedish study based on 
women’s own country of origin.72 Evidence for a higher risk of endometriosis among women 
born to mothers from the former Soviet states is limited. We speculate that this association 
might be partially related to perceived psychosocial stress among women during their 
childhood, which is a contributing factor to endometriosis.135 This potential mechanism 
however deserves more research.  
For adult reproductive characteristics, we found lower number of live births and prior 
infertility disorder to predict subsequent risk of external endometriosis. The risk was however 
not related to women’s ages at first and last birth. The inverse dose-response association 
between number of live births and later risk of endometriosis is expected and well in line with 
the menstrual reflux mechanism. Menstrual reflux is one of important prerequisites for the 
development and establishment of endometriosis, therefore more frequent exposure to 
menstruation among women with fewer children will increase the chance for endometrial 
fragments to implant in the peritoneal cavity and result in ectopic uterine mucosa.62 In 
addition, the high levels of progestin and prolactin during pregnancy and lactation might 
inhibit the progress of endometriosis through interrupting regular estrogen production.131 
Nevertheless, considering infertility is a known consequence of endometriosis, and we can 
only capture the time at diagnosis instead of onset of the disorder, fewer live births might thus 
be a result rather than the cause for endometriosis.   
The menstrual reflux mechanism however does not apply to uterine adenomyosis. We 
detected a non-significant trend towards a higher risk of adenomyosis among women with 
greater number of live births. The potential underlying mechanism might be their more 
frequent exposure to uterine trauma, which has been suggested as a pathogenesis of 
adenomyosis.76 77 
7.1.4 Psychiatric comorbidity in women with endometriosis 
It is well known that endometriosis could lead to psychological suffering,25,26 due to its 
incurable condition and related consequences, such as chronic pelvic pain, dysmenorrhea, and 
infertility. However, considering that endometriosis and mental disorders are both mainly 
heritable, the psychiatric burden among women with endometriosis may be caused by 
underlying familial confounding. In Study III, we identified a broad comorbidity between 
endometriosis and many psychiatric disorders. Our findings also showed that shared familial 
liability could only partially explain these comorbid associations. Therefore, apart from 
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familial susceptibility to both disorders, other explanations may account for the overlap 
between endometriosis and many mental disorders.     
We speculate that common causes including immune dysregulation and early exposure to 
environmental contaminants, such as polychlorinated biphenyls and dioxins may contribute 
to the progression of endometriosis and multiple mental disorders, making women 
susceptible to develop both conditions.9,65,136-138 The higher rates of being later diagnosed 
with mental disorders in women with prior endometriosis could be the direct result of adverse 
consequences of endometriosis, which may amplify mental distress in these women.80,139-141 
The medical care for physical consequences of endometriosis, e.g., pelvic pain, could also 
increase the detection or diagnosis of mental disorders among affected women. Additionally, 
some common hormonal medications used to treat the symptoms or consequences of 
endometriosis, e.g., gonadotropin-releasing hormone agonists and oral contraceptives have 
been linked to multiple psychiatric side effects and could potentially increase the risks of 
depression and anxiety disorders among the users.142-147  
We also found that there was an increased risk of being later diagnosed with endometriosis 
among women with mental disorders. This could be explained by increased detection given 
that women with mental ill health may be already in contact with healthcare. It could also be 
that women with psychiatric disorders may suffer from more severe endometriosis symptoms 
thus more likely to be diagnosed.148,149  
Despite the fact that the bi-directional associations observed in our study might be biased by 
reverse causality, our findings nevertheless demonstrated a high degree of comorbidity 
between endometriosis and many mental disorders. Clinically, the psychiatric comorbidity in 
women with endometriosis should be better recognized and treated with a multidisciplinary 
approach. 
7.1.5 Developmental origins of perimenopausal disorders 
From study I and II, we found out that there is a developmental origins effect on a common 
female hormone-related disorder during the reproductive years, namely endometriosis. In 
study IV we have investigated whether a similar effect could be identified for perimenopausal 
disorders (PDs), a group of disorders also partially driven by hormonal changes in the 
end/after the reproductive period. Contrary to the negative effect from low birth weight on 
endometriosis, we found that high birth weight was associated with an increased risk of 
menopausal and climacteric states, such as hot flushes, sleeplessness, and headache.  
Unlike other important female health burdens, e.g., reproductive cancers and early 
menopause,150-152 evidence on the developmental origins effect with regard to PDs was 
limited. It was thus difficult for us to compare our results with previous research directly. But 
we speculate that one possible explanation for the observed positive association between birth 
weight and risk of menopausal and climacteric states is through adult overweight or obesity 
caused by higher birth weight.  
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It is well-known that higher weight at birth is associated with higher body mass index (BMI) 
or obesity in adulthood.153 The association between adult BMI and menopausal symptoms is 
nevertheless not straightforward. An earlier large population-based cohort study showed that 
higher adult BMI was associated with less risk of experiencing menopausal symptoms among 
postmenopausal women.154 A possible explanation is that menopausal symptoms, particularly 
vasomotor-related symptoms, are improved by high estrogen levels produced by the greater 
quantities of adipose tissue during postmenopausal period.155,156   
However, inverse associations of adult BMI with estrogen levels and menopausal symptoms 
were found among perimenopausal women or women who undergo menopausal 
transition.100,157-159 For example, a previous study based on perimenopausal women (45-54 
years) showed that higher BMI was associated with an increased risk of hot flushes. Potential 
mechanisms involve lower estradiol levels and earlier onset of ovarian insufficiency (one 
phenomenon of early menopause) in obese women.99 Relatedly, previous studies have 
suggested an association between higher birth weight and earlier menopause, although the 
role of adult BMI mediating such association was not investigated.27,28  
Taken together, we speculate that the observed positive association between birth weight and 
menopausal and climacteric status in our study could be indirectly explained by higher adult 
BMI and lower estrogen levels during perimenopausal period. This speculation is partly 
supported by many studies in which adult BMI was found negatively associated with 
estradiol in women during premenopausal period but reversed during postmenopausal 
period.160-162 Nevertheless, further research is warranted into the underlying mechanism, 
including potential upstream determinants such as maternal diabetes or overnutrition during 
the fetal period.  
In this study we also found that the risk of perimenopausal bleeding disorders was not related 
to birth weight or gestational age. This lack of association is somewhat expected, considering 
perimenopausal abnormal bleeding is an indicator of potential gynecological lesions or 
malignancies, which were found not to be related to birth weight according to a meta-
analysis.150  
We speculate that the association between shorter length of gestation and other PDs, e.g., 
vaginal or endometrial atrophy could reflect the influence from the prenatal period on the 
development of ovarian function and reproductive organs. To sum up, Study IV supports the 
developmental origins theory with respect to PDs and suggests that the prenatal period is a 
sensitive period for organ development and subsequent disease risk in which non-optimal 
intrauterine environment may have long-term effects on health even during the 
perimenopausal period.  
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7.2 METHODOLOGICAL CONSIDERATIONS  
7.2.1 Misclassification and generalizability 
The use of longitudinal data prospectively collected from comprehensive population-based 
registers is the main strength of this thesis. However, our register-based design to identify 
cases is also a source of limitation towards potential misclassification, and this applies to all 
health outcomes examined in this thesis, i.e., endometriosis, psychiatric disorders, and PDs.  
We used secondary care data from hospitalization and outpatient specialist records to 
ascertain cases, thus women with a disorder in question who did not seek medical care would 
not be captured and will be treated as disorder-free. Presumably, we might miss a 
considerable number of cases among women who did not seek medical care due to less 
severe symptoms, not being accurately diagnosed, or treated within primary care. The 
potential under-diagnosis of cases could also explain why prevalence of endometriosis or PDs 
found in this thesis was lower than when estimated from population level or survey-based 
design.54,92 Nevertheless, we think the outcome misclassification is unlikely to be differential 
with regards to exposure status, for example, a woman would not be overlooked for 
endometriosis because of her lower weight at birth, which would not bias our observed 
associations.  
Misclassification bias might be more pronounced in sibling comparison analysis in Study III, 
considering that both endometriosis and psychiatric disorders tend to cluster within families, 
e.g., women with endometriosis might imply an undiagnosed condition in the “unexposed” 
sister. If some pairs of sisters who are in reality concordant for the exposure were treated as 
discordant in the sibling analysis, then the true association will be underestimated. It is 
however possible that this misclassification bias could be somewhat counterbalanced by the 
potential carryover effect among sisters, e.g., endometriosis condition in one sister might 
increase the detection in another sister.  
Moreover, the potential misclassification limits the generalizability of our study findings to 
women with subclinical symptoms of mental disorders and those with milder symptoms of 
endometriosis and PDs.  
7.2.2 Confounding 
In this thesis, we have tried to reduce confounding bias through adjustment for prospectively 
recorded earlier life factors than the exposure, the E-value measure, and family-based 
designs. However, in both conventional confounding controlled model and family-based 
designs, study findings may still be biased from unmeasured factors that are causally linked 
with both the exposure and the outcome but are not on the causal pathway. If this is the case, 
any observed associations from sibling comparison analysis will be more biased by non-
shared confounding than population level analysis.163  
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7.2.3 Sibling comparison  
Apart from inability to control unmeasured family-varying confounding factors, the sibling 
comparison may also be biased by “accidently” controlling for shared covariates that are on 
the causal pathway of the exposure-outcome association. The adjustment for potential 
mediators shared by the sisters may dilute the true causal effect from the exposure.164 
Therefore, if attenuation in estimations was observed in sibling comparison analysis 
compared to population-level analysis, the results should be interpreted with caution. The 
lack of relationships in some exposure-outcome associations in Studies II and III may not 
only be explained by the presence of shared confounding (e.g., genetic or familial 
environmental factors) but may also be due to shared mediators (e.g., living conditions, 
physical health, or life-style factors) or simply result from low statistical power in the reduced 
sample size. 
In addition, the sibling comparison design assumes no sibling carryover or contagion effects, 
which means the exposure and outcome of one sibling should not affect the exposure and 
outcome of the other sibling(s).165 In Study II, considering the long-term associations of 
maternal and birth characteristics with endometriosis in reproductive period, estimations from 
within-family analysis are unlikely to be affected by carryover effect. Although it is possible 
that maternal smoking in the previous pregnancy may increase the risk of the same behavior 
in the current pregnancy, the results would be less biased in the presence of this type of 
exposure-to-exposure carryover.165  
The associations of endometriosis with psychiatric disorders in Study III may however be 
biased by the outcome-to-outcome carryover (contagion) effect, e.g., psychiatric disorder in 
one sister may affect the mental health in another sister. In this case, we may underestimate 
the true association between endometriosis and psychiatric disorders.  
7.3 FUTURE PERSPECTIVES 
In life course epidemiology, long-term associations of early life exposures and adult health 
outcomes are often observed. The next step would be to clarify and quantify potential 
mechanisms that explain these life course associations. In this thesis, we have found 
associations of parental, birth, and early adult characteristics with risks of endometriosis and 
PDs. However, we were not able to fully identify their potential mechanistic pathways or 
accumulation of risks from factors operating in different life stages, which may be helpful for 
understanding the underlying etiology or targeting earlier interventions.  
There are several questions that need to be addressed by further research. First, in Studies I 
and II we observed an inverse association between fetal growth rate and risk of 
endometriosis, which cannot be fully explained by familial confounding factors. We thus 
wonder whether there are mechanisms through adult factors, such as BMI or hormone levels. 
A previous study showed that endometriosis was more prevalent among women with lower 
weight in adolescence and early adulthood, which is contradictory to its estrogen-dependent 
disease pathology.166 It would thus be informative to examine whether and to what extent 
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lower adult BMI could mediate the adverse effect from low weight or slow growth during the 
prenatal period, and whether there may be an interaction effect between weight at birth and in 
early adulthood on hormonal levels in adulthood.  
Furthermore, in Study II we found that maternal smoking during early pregnancy was 
associated with an elevated risk of endometriosis. There was also evidence showing that 
exposure to passive smoking in childhood may possibly increase the risk of endometriosis.132 
Considering that mother’s smoking behavior during pregnancy might imply parental smoking 
in one’s childhood, it is still unknow whether the adverse effect on endometriosis is from 
fetal programming or a postnatal environmental effect. If both are possible, it is worth to 
further explore the sensitive period when environmental toxicant exposures exert strongest 
effects on the development of endometriosis.  
Moreover, Study III showed that women with endometriosis were at an increased risk for 
several mental disorders, such as depression, anxiety and stress-related disorders, and 
alcohol/drug dependence. Among many other factors, e.g., familial susceptibility and 
immune-system dysregulation, it is plausible that these mental distresses are caused by the 
adverse consequences of endometriosis, such as chronic pelvic pain and subfertility. 
Therefore, a primary goal for future research is to explore the potential mechanism explaining 
associations between endometriosis and psychiatric disorders, which could help to identify 
high-risk groups for targeted prevention and management of mental disorders among women 
with endometriosis.   
Additionally, it is worthwhile to emphasize and thoroughly investigate the social 
determinants of endometriosis and PDs, such as their associations with social mobility; and to 
try to detect sensitive periods in which socioeconomic position may create the gradient in ill-
health. These social determinants might be important underlying contributing factors of the 
predictors observed in our studies, such as maternal smoking during pregnancy, stress related 
disorders, or alcohol/drug dependence. Research into the upstream determinants can thus 
provide important clues to prevent the reproduction of health inequalities over the life course 
and across generations. 
It should also be noted that, our measures of women’s socioeconomic position were mainly 
based on education and income. Previous studies have argued that these may not be the best 
predictors when assessing social inequalities in health among women.167,168 It could be that 
other aspects of social inequality in women remain uncovered by these one-dimensional 
measures, thus leading to residual confounding. Future research with available data could 
consider exploring the social patterning of these female disorders with additional measures 
such as general social advantage (e.g., income) in the household or partner’s social 
class.167,169,170  
Last yet important, this thesis has demonstrated a positive association between birth weight 
and risk of menopausal and climacteric status, although mechanisms explaining this 
association remain uncertain. More research is required to investigate the potential 
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mechanistic pathways through, for example, adult BMI and hormone levels. Further 
exploring whether our observed association may vary with women’s menopausal status could 






This thesis has found associations of maternal smoking during pregnancy and slow fetal 
growth rate with endometriosis, and of high birth weight with menopausal and climacterics 
states. The findings from this thesis support the developmental adaptation mechanism with 
respect to these female hormone-driven disorders. During a critical or sensitive period of life, 
exposure to environmental insults, such as toxic components and undernutrition, may 
permanently alter the programming of body structure, physiology, and metabolism,17 which 
in turn makes some women more susceptible to develop certain diseases/disorders.  
From a methodological perspective, this thesis demonstrated the value of combining large 
register-based population studies with family-based study designs for identification and 
quantification of residual genetic and shared (familial) environmental confounding in adult 
disorders with early life origins.   
As also shown in this thesis, disorders during women’s reproductive and perimenopausal 
period were associated with a range of socioeconomic, demographic, and mental factors 
operating in the early life stages and across generations. These factors likely exert a chain of 
cumulative influences on observed inequalities in health, with social factors as the upstream 
determinants.  
Taken together, this thesis highlights the need to bring a life course perspective into research 
on women’s health outcomes. This could help to better identify the groups of women who are 
particularly at risk and might also guide prevention strategies and disease management. It 
should be noted that the developmental origins of health and disease (DOHaD) effect is not 
only a biological issue but also a public health issue. To prevent adverse health outcomes that 
originate from early life, joint efforts - with consideration of downstream effects of social 
inequalities - are needed from various stakeholders, including policy makers, health 
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